OHSU Knight Cancer Institute Research Groups:OCI Cancer Journal Club - Revision history

Jeni Wroblewski: /* Schedule */

2013-06-04T16:58:23Z

Schedule

←Older revision		Revision as of 16:58, 4 June 2013
Line 210:		Line 210:
	\|Marcus Calkins		\|Marcus Calkins
	\|The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation		\|The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation
-	\|	+	\|[http://openwetware.org/images/5/5c/EEF2_kinase_confers_resistance_to_ND.pdf]
	\|}		\|}
	</div>		</div>

2013-06-04T16:56:51Z

Schedule

←Older revision		Revision as of 16:56, 4 June 2013
Line 209:		Line 209:
	\|6/6/2013		\|6/6/2013
	\|Marcus Calkins		\|Marcus Calkins
-	\|"The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation"	+	\|The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation
	\|		\|
	\|}		\|}
	</div>		</div>

2013-06-04T16:56:32Z

Schedule

←Older revision		Revision as of 16:56, 4 June 2013
Line 209:		Line 209:
	\|6/6/2013		\|6/6/2013
	\|Marcus Calkins		\|Marcus Calkins
-	\|	+	\|"The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation"
	\|		\|
	\|}		\|}
	</div>		</div>

2013-05-30T17:47:31Z

Schedule

←Older revision		Revision as of 17:47, 30 May 2013
Line 205:		Line 205:
	\|Mahnaz Janghorban		\|Mahnaz Janghorban
	\|Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer		\|Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer
-	\|	+	\|[http://openwetware.org/images/b/b2/Loss_of_FBP1_by_Snail-Mediated_Repression_Provides_Metabolic_Advantages_in_Basal-like_Breast_Cancer.pdf Dong et al]
	\|--		\|--
	\|6/6/2013		\|6/6/2013

2013-05-30T17:45:53Z

Schedule

←Older revision		Revision as of 17:45, 30 May 2013
Line 204:		Line 204:
	\|5/30/2013		\|5/30/2013
	\|Mahnaz Janghorban		\|Mahnaz Janghorban
-	\|	+	\|Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer
	\|		\|
	\|--		\|--

2013-05-20T14:52:07Z

Schedule

←Older revision		Revision as of 14:52, 20 May 2013
Line 199:		Line 199:
	\|5/23/2013		\|5/23/2013
	\|Dr. Charles Lopez		\|Dr. Charles Lopez
-	\|	+	\|CANCELED DUE TO RESEARCH WEEK
	\|		\|
	\|--		\|--

2013-05-14T14:55:34Z

Schedule

←Older revision		Revision as of 14:55, 14 May 2013
Line 195:		Line 195:
	\|Xiaoxin Sun		\|Xiaoxin Sun
	\|Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP		\|Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP
-	\|	+	\|[http://openwetware.org/images/5/5f/Cancer_journal_club_paper.pdf]
	\|--		\|--
	\|5/23/2013		\|5/23/2013

2013-05-14T14:54:47Z

Schedule

←Older revision		Revision as of 14:54, 14 May 2013
Line 194:		Line 194:
	\|5/16/201		\|5/16/201
	\|Xiaoxin Sun		\|Xiaoxin Sun
-	\|	+	\|Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP
	\|		\|
	\|--		\|--

2013-05-08T16:46:53Z

Schedule

←Older revision		Revision as of 16:46, 8 May 2013
Line 190:		Line 190:
	\|Juan Liang		\|Juan Liang
	\|Inhibition of RNA Polymerase I as a Therapeutic Strategy to Promote Cancer-Specific Activation of p53		\|Inhibition of RNA Polymerase I as a Therapeutic Strategy to Promote Cancer-Specific Activation of p53
-	\|	+	\|[http://openwetware.org/images/0/0e/2012_Cance_Cell_Inhibition_of_RNA_Polymerase_I_as_a_Therapeutic_Strategy.pdf]
	\|--		\|--
	\|5/16/201		\|5/16/201

2013-05-08T16:44:41Z

Schedule

←Older revision		Revision as of 16:44, 8 May 2013
Line 189:		Line 189:
	\|5/9/2013		\|5/9/2013
	\|Juan Liang		\|Juan Liang
-	\|	+	\|Inhibition of RNA Polymerase I as a Therapeutic Strategy to Promote Cancer-Specific Activation of p53
	\|		\|
	\|--		\|--